Pulmonary Hypertension Program
Research and Education
Advances in PH Research
 |
|
Pictured from left to right are Jessica Lazar, M.P.A., P.A.-C., Michele Svitek, R.N., B.S.N., Srinivas Murali, M.D., |
Dr. Murali and his staff have been involved in research for new PH treatments for the past 16 years.They have participated in many of the landmark clinical trials that have led to the development and FDA approval of currently available therapies. Clinical trials presently underway are exploring new treatment options such as an oral prostanoid, selective endothelin receptor blockers, and combination strategies. In addition, epidemiologic and genetic studies are being pursued to explore the risk factors for PH and genetic modulation of treatment responses, which will further improve our ability to care for PH patients.
PH Preceptorship Program
The PH program at AGH offers a day-long preceptorship for physicians and allied health professionals who are interested in the development and implementation of a comprehensive management system for PH patients in their practice. The preceptorship includes didactic sessions that are tailored to meet the needs of the participants, hands-on experience in a PH clinic, and case discussions with PH specialists. Arrangements for preceptorship can be made by contacting Jessica Lazar, MPA, PA-C at 412-359-3345.
